1,3-Bis-(1-methyl-1H-indol-3-yl)-propenone

ID: ALA1834570

PubChem CID: 56678496

Max Phase: Preclinical

Molecular Formula: C21H18N2O

Molecular Weight: 314.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(/C=C/C(=O)c2cn(C)c3ccccc23)c2ccccc21

Standard InChI:  InChI=1S/C21H18N2O/c1-22-13-15(16-7-3-5-9-19(16)22)11-12-21(24)18-14-23(2)20-10-6-4-8-17(18)20/h3-14H,1-2H3/b12-11+

Standard InChI Key:  YAKSLYJQYXCGCH-VAWYXSNFSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.9957    0.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2797    0.5873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4332    1.0024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1171   -0.3098    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3017   -0.1838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1697    0.6305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9033    1.0078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1139    1.8054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9100    2.0219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4955    1.4408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2849    0.6431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4889    0.4266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4943   -1.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0133    0.2996    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4636    0.9147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7087    0.5819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7918   -0.2389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2376   -0.8499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4896   -1.6355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2959   -1.8100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8502   -1.1989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5982   -0.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8341    0.3827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4302    1.8274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  4 12  1  0
  7 12  2  0
  4 13  1  0
  3  6  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 14 22  1  0
 17 22  2  0
 14 23  1  0
  1 16  1  0
  3 24  2  0
M  END

Alternative Forms

Associated Targets(Human)

RT-112 (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCG2 Tchem ATP-binding cassette sub-family G member 2 (4927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 314.39Molecular Weight (Monoisotopic): 314.1419AlogP: 4.57#Rotatable Bonds: 3
Polar Surface Area: 26.93Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.54CX LogD: 4.54
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.40Np Likeness Score: -0.45

References

1. Martel-Frachet V, Kadri M, Boumendjel A, Ronot X..  (2011)  Structural requirement of arylindolylpropenones as anti-bladder carcinoma cells agents.,  19  (20): [PMID:21908193] [10.1016/j.bmc.2011.08.015]
2. Valdameri G, Gauthier C, Terreux R, Kachadourian R, Day BJ, Winnischofer SM, Rocha ME, Frachet V, Ronot X, Di Pietro A, Boumendjel A..  (2012)  Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.,  55  (7): [PMID:22449016] [10.1021/jm2016528]

Source